
May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
May 6, 2016 Medical Communications, Sales and Marketing Amgen, Draft Guidance, NHS, NICE, Repatha, Sanofi, cardiovascular disease, cholesterol, final draft guidance, high cholesterol, praluent, recommendation, treatment

May 6, 2016 Medical Communications, Sales and Marketing

May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war

May 6, 2016 Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales

May 6, 2016 Medical Communications, Sales and Marketing Valeant, joseph papa, new committee, patient access, price gouging, pricing

May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences

May 5, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Medivation, Sanofi, board, brandicourt, hostile, shareholders, takeover

May 5, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, antibiotic, prescribing, prescriptions, unnecessary

May 3, 2016 Medical Communications, Research and Development, Sales and Marketing IMS Health, Quintiles, merger

May 3, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, cfo, kenneth parks

May 3, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, GSK, Pfizer, analysis, medicins sans frontieres, patents, pneumonia

April 29, 2016 Medical Communications, Sales and Marketing Medivation, Sanofi, board, hostile, rejection, takeover

April 29, 2016 Medical Communications NICE, Novartis, combination therapy, regulation, skin cancer